In the last trading session, 23.64 million Lineage Cell Therapeutics Inc (AMEX:LCTX) shares changed hands as the company’s beta touched 1.61. With the company’s per share price at $0.94 changed hands at -$0.02 or -3.02% during last session, the market valuation stood at $213.56M. LCTX’s last price was a discount, traded about -22.34% off its 52-week high of $1.15. The share price had its 52-week low at $0.37, which suggests the last value was 60.64% up since then. When we look at Lineage Cell Therapeutics Inc’s average trading volume, we note the 10-day average is 6.25 million shares, with the 3-month average coming to 1.72 million.
Lineage Cell Therapeutics Inc (AMEX:LCTX) trade information
Instantly LCTX was in red as seen at the end of in last trading. With action -1.56%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 2.31%, with the 5-day performance at -1.56% in the red. However, in the 30-day time frame, Lineage Cell Therapeutics Inc (AMEX:LCTX) is 43.37% up. Looking at the short shares, we see there were 28.73 million shares sold at short interest cover period of 19.99 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -2.93%. The 2025 estimates are for Lineage Cell Therapeutics Inc earnings to decrease by -9.73%, but the outlook for the next 5-year period is at 9.01% per year.
LCTX Dividends
Lineage Cell Therapeutics Inc is expected to release its next quarterly earnings report on 2025-May-13.
Lineage Cell Therapeutics Inc (AMEX:LCTX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.42% of Lineage Cell Therapeutics Inc shares while 47.94% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 48.14%. There are 47.94% institutions holding the Lineage Cell Therapeutics Inc stock share, with BROADWOOD CAPITAL INC the top institutional holder. As of 2024-06-30, the company held 22.0675% of the shares, roughly 41.67 million LCTX shares worth $41.55 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 5.0629% or 9.56 million shares worth $9.53 million as of 2024-06-30.
